APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alpha-1 Antitrypsin Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Alpha-1 Antitrypsin Drugs Industry Growth and Trends Forecast to 2032

20 December 202592 pages

Choose your research edition.

Industry ResearchAlpha-1 Antitrypsin Drugs Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Alpha-1 Antitrypsin Drugs Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Alpha-1 Antitrypsin Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alpha-1 Antitrypsin Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Alpha-1 Antitrypsin Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Alpha-1 Antitrypsin Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Alpha-1 Antitrypsin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Alpha-1 Antitrypsin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alpha-1 Antitrypsin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Alpha-1 Antitrypsin Drugs include Baxter, Kamada, Grifols, CSL Behring, Baxalta, Arrowhead Research Corporation, Applied Genetic Technologies Corp, Alnylam Pharmaceuticals and Abeona Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Alpha-1 Antitrypsin Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Alpha-1 Antitrypsin Drugs market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Alpha-1 Antitrypsin Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Alpha-1 Antitrypsin Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Alpha-1 Antitrypsin Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Alpha-1 Antitrypsin Drugs Market by Company

Baxter

Kamada

Grifols

CSL Behring

Baxalta

Arrowhead Research Corporation

Applied Genetic Technologies Corp

Alnylam Pharmaceuticals

Abeona Therapeutics

Alpha-1 Antitrypsin Drugs Segment by Type

Parenteral

Inhalation

Alpha-1 Antitrypsin Drugs Segment by Application

Drugstore

Hospital

Others

Alpha-1 Antitrypsin Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alpha-1 Antitrypsin Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alpha-1 Antitrypsin Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alpha-1 Antitrypsin Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Alpha-1 Antitrypsin Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Alpha-1 Antitrypsin Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Parenteral Table 2. Major Company of Inhalation Table 3. Global Alpha-1 Antitrypsin Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (W Units) Table 5. Global Alpha-1 Antitrypsin Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Alpha-1 Antitrypsin Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Alpha-1 Antitrypsin Drugs Price by Type (2021-2026) & (US$/Unit) Table 9. Global Alpha-1 Antitrypsin Drugs Sales by Type (2027-2032) & (W Units) Table 10. Global Alpha-1 Antitrypsin Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Alpha-1 Antitrypsin Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Alpha-1 Antitrypsin Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Alpha-1 Antitrypsin Drugs Price by Type (2027-2032) & (US$/Unit) Table 14. North America Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (W Units) Table 15. North America Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (W Units) Table 17. Europe Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (W Units) Table 19. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (W Units) Table 21. Latin America Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (W Units) Table 23. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Alpha-1 Antitrypsin Drugs Industry Trends Table 25. Alpha-1 Antitrypsin Drugs Industry Drivers Table 26. Alpha-1 Antitrypsin Drugs Industry Opportunities and Challenges Table 27. Alpha-1 Antitrypsin Drugs Industry Restraints Table 28. Global Alpha-1 Antitrypsin Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Alpha-1 Antitrypsin Drugs Sales by Company (2021-2026) & (W Units) Table 31. Global Alpha-1 Antitrypsin Drugs Sales Share by Company (2021-2026) Table 32. Global Alpha-1 Antitrypsin Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Alpha-1 Antitrypsin Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Alpha-1 Antitrypsin Drugs Major Company Production Sites and Headquarters Table 35. Global Alpha-1 Antitrypsin Drugs Company, Product Type & Application Table 36. Global Alpha-1 Antitrypsin Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Alpha-1 Antitrypsin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Alpha-1 Antitrypsin Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Alpha-1 Antitrypsin Drugs Sales by Region (2021-2026) & (W Units) Table 41. Global Alpha-1 Antitrypsin Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Alpha-1 Antitrypsin Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Alpha-1 Antitrypsin Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Alpha-1 Antitrypsin Drugs Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Alpha-1 Antitrypsin Drugs Sales by Region (2027-2032) & (W Units) Table 46. Global Alpha-1 Antitrypsin Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Alpha-1 Antitrypsin Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Alpha-1 Antitrypsin Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Alpha-1 Antitrypsin Drugs Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Alpha-1 Antitrypsin Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (W Units) Table 52. Global Alpha-1 Antitrypsin Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Alpha-1 Antitrypsin Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Alpha-1 Antitrypsin Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Alpha-1 Antitrypsin Drugs Sales by Application (2027-2032) & (W Units) Table 57. Global Alpha-1 Antitrypsin Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Alpha-1 Antitrypsin Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Alpha-1 Antitrypsin Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Alpha-1 Antitrypsin Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. North America Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (W Units) Table 62. North America Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (W Units) Table 64. Europe Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (W Units) Table 66. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (W Units) Table 68. Latin America Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (W Units) Table 70. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Baxter Company Information Table 72. Baxter Business Overview Table 73. Baxter Alpha-1 Antitrypsin Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Baxter Alpha-1 Antitrypsin Drugs Product Portfolio Table 75. Baxter Recent Development Table 76. Kamada Company Information Table 77. Kamada Business Overview Table 78. Kamada Alpha-1 Antitrypsin Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Kamada Alpha-1 Antitrypsin Drugs Product Portfolio Table 80. Kamada Recent Development Table 81. Grifols Company Information Table 82. Grifols Business Overview Table 83. Grifols Alpha-1 Antitrypsin Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Grifols Alpha-1 Antitrypsin Drugs Product Portfolio Table 85. Grifols Recent Development Table 86. CSL Behring Company Information Table 87. CSL Behring Business Overview Table 88. CSL Behring Alpha-1 Antitrypsin Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. CSL Behring Alpha-1 Antitrypsin Drugs Product Portfolio Table 90. CSL Behring Recent Development Table 91. Baxalta Company Information Table 92. Baxalta Business Overview Table 93. Baxalta Alpha-1 Antitrypsin Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Baxalta Alpha-1 Antitrypsin Drugs Product Portfolio Table 95. Baxalta Recent Development Table 96. Arrowhead Research Corporation Company Information Table 97. Arrowhead Research Corporation Business Overview Table 98. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product Portfolio Table 100. Arrowhead Research Corporation Recent Development Table 101. Applied Genetic Technologies Corp Company Information Table 102. Applied Genetic Technologies Corp Business Overview Table 103. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product Portfolio Table 105. Applied Genetic Technologies Corp Recent Development Table 106. Alnylam Pharmaceuticals Company Information Table 107. Alnylam Pharmaceuticals Business Overview Table 108. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product Portfolio Table 110. Alnylam Pharmaceuticals Recent Development Table 111. Abeona Therapeutics Company Information Table 112. Abeona Therapeutics Business Overview Table 113. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product Portfolio Table 115. Abeona Therapeutics Recent Development Table 116. North America Alpha-1 Antitrypsin Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 117. North America Alpha-1 Antitrypsin Drugs Sales by Country (2021-2026) & (W Units) Table 118. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2021-2026) Table 119. North America Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 120. North America Alpha-1 Antitrypsin Drugs Sales Market Share Forecast by Country (2027-2032) Table 121. North America Alpha-1 Antitrypsin Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Alpha-1 Antitrypsin Drugs Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Alpha-1 Antitrypsin Drugs Market Share by Country (2021-2026) Table 124. North America Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Alpha-1 Antitrypsin Drugs Market Share Forecast by Country (2027-2032) Table 126. Europe Alpha-1 Antitrypsin Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 127. Europe Alpha-1 Antitrypsin Drugs Sales by Country (2021-2026) & (W Units) Table 128. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2021-2026) Table 129. Europe Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 130. Europe Alpha-1 Antitrypsin Drugs Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Alpha-1 Antitrypsin Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Alpha-1 Antitrypsin Drugs Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Alpha-1 Antitrypsin Drugs Market Share by Country (2021-2026) Table 134. Europe Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Alpha-1 Antitrypsin Drugs Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Alpha-1 Antitrypsin Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales by Country (2021-2026) & (W Units) Table 138. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 140. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Alpha-1 Antitrypsin Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Alpha-1 Antitrypsin Drugs Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Alpha-1 Antitrypsin Drugs Market Share by Country (2021-2026) Table 144. Asia-Pacific Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Alpha-1 Antitrypsin Drugs Market Share Forecast by Country (2027-2032) Table 146. Latin America Alpha-1 Antitrypsin Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 147. Latin America Alpha-1 Antitrypsin Drugs Sales by Country (2021-2026) & (W Units) Table 148. Latin America Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2021-2026) Table 149. Latin America Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 150. Latin America Alpha-1 Antitrypsin Drugs Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Alpha-1 Antitrypsin Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Alpha-1 Antitrypsin Drugs Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Alpha-1 Antitrypsin Drugs Market Share by Country (2021-2026) Table 154. Latin America Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Alpha-1 Antitrypsin Drugs Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Alpha-1 Antitrypsin Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Country (2021-2026) & (W Units) Table 158. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 160. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Alpha-1 Antitrypsin Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Alpha-1 Antitrypsin Drugs Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Alpha-1 Antitrypsin Drugs Market Share by Country (2021-2026) Table 164. Middle East and Africa Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Alpha-1 Antitrypsin Drugs Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Alpha-1 Antitrypsin Drugs Distributors List Table 169. Alpha-1 Antitrypsin Drugs Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Alpha-1 Antitrypsin Drugs Image Figure 2. Global Alpha-1 Antitrypsin Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alpha-1 Antitrypsin Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Alpha-1 Antitrypsin Drugs Sales (2021-2032) & (W Units) Figure 5. Parenteral Image Figure 6. Global Parenteral Sales YoY Growth (2021-2032) & (W Units) Figure 7. Inhalation Image Figure 8. Global Inhalation Sales YoY Growth (2021-2032) & (W Units) Figure 9. Global Alpha-1 Antitrypsin Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Alpha-1 Antitrypsin Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Alpha-1 Antitrypsin Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Alpha-1 Antitrypsin Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Alpha-1 Antitrypsin Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Alpha-1 Antitrypsin Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Alpha-1 Antitrypsin Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Alpha-1 Antitrypsin Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Alpha-1 Antitrypsin Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Drugstore Image Figure 24. Global Drugstore Sales YoY Growth (2021-2032) & (W Units) Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 29. Global Alpha-1 Antitrypsin Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Alpha-1 Antitrypsin Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Alpha-1 Antitrypsin Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Alpha-1 Antitrypsin Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Alpha-1 Antitrypsin Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Alpha-1 Antitrypsin Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Alpha-1 Antitrypsin Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Alpha-1 Antitrypsin Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Alpha-1 Antitrypsin Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 42. North America Alpha-1 Antitrypsin Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Alpha-1 Antitrypsin Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Alpha-1 Antitrypsin Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Alpha-1 Antitrypsin Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. Europe Alpha-1 Antitrypsin Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Alpha-1 Antitrypsin Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Alpha-1 Antitrypsin Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Alpha-1 Antitrypsin Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Alpha-1 Antitrypsin Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Alpha-1 Antitrypsin Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Latin America Alpha-1 Antitrypsin Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Alpha-1 Antitrypsin Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Alpha-1 Antitrypsin Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Alpha-1 Antitrypsin Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Alpha-1 Antitrypsin Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Alpha-1 Antitrypsin Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Alpha-1 Antitrypsin Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Parenteral
  • Inhalation
Applications
  • Drugstore
  • Hospital
  • Others
Companies covered
  • Baxter
  • Kamada
  • Grifols
  • CSL Behring
  • Baxalta
  • Arrowhead Research Corporation
  • Applied Genetic Technologies Corp
  • Alnylam Pharmaceuticals
  • Abeona Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Alpha-1 Antitrypsin Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Alpha-1 Antitrypsin Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Alpha-1 Antitrypsin Drugs Market by Type
  6. 1.3.1 Parenteral
  7. 1.3.2 Inhalation
  8. 1.4 Global Alpha-1 Antitrypsin Drugs Market Size by Type
  9. 1.4.1 Global Alpha-1 Antitrypsin Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Alpha-1 Antitrypsin Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Alpha-1 Antitrypsin Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Alpha-1 Antitrypsin Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Alpha-1 Antitrypsin Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Alpha-1 Antitrypsin Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Alpha-1 Antitrypsin Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Alpha-1 Antitrypsin Drugs Industry Trends
  2. 2.2 Alpha-1 Antitrypsin Drugs Industry Drivers
  3. 2.3 Alpha-1 Antitrypsin Drugs Industry Opportunities and Challenges
  4. 2.4 Alpha-1 Antitrypsin Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Alpha-1 Antitrypsin Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Alpha-1 Antitrypsin Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Alpha-1 Antitrypsin Drugs Price (2021-2026)
  4. 3.4 Global Alpha-1 Antitrypsin Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Alpha-1 Antitrypsin Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Alpha-1 Antitrypsin Drugs Company, Product Type & Application
  7. 3.7 Global Alpha-1 Antitrypsin Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Alpha-1 Antitrypsin Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Alpha-1 Antitrypsin Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Alpha-1 Antitrypsin Drugs Tier 1, Tier 2, and Tier 3
4 Alpha-1 Antitrypsin Drugs Regional Status and Outlook
  1. 4.1 Global Alpha-1 Antitrypsin Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Alpha-1 Antitrypsin Drugs Historic Market Size by Region
  3. 4.2.1 Global Alpha-1 Antitrypsin Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Alpha-1 Antitrypsin Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Alpha-1 Antitrypsin Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Alpha-1 Antitrypsin Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Alpha-1 Antitrypsin Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Alpha-1 Antitrypsin Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Alpha-1 Antitrypsin Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Alpha-1 Antitrypsin Drugs by Application
  1. 5.1 Alpha-1 Antitrypsin Drugs Market by Application
  2. 5.1.1 Drugstore
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Alpha-1 Antitrypsin Drugs Market Size by Application
  6. 5.2.1 Global Alpha-1 Antitrypsin Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Alpha-1 Antitrypsin Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Alpha-1 Antitrypsin Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Alpha-1 Antitrypsin Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Alpha-1 Antitrypsin Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Alpha-1 Antitrypsin Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Alpha-1 Antitrypsin Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Baxter
  2. 6.1.1 Baxter Company Information
  3. 6.1.2 Baxter Business Overview
  4. 6.1.3 Baxter Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Baxter Alpha-1 Antitrypsin Drugs Product Portfolio
  6. 6.1.5 Baxter Recent Developments
  7. 6.2 Kamada
  8. 6.2.1 Kamada Company Information
  9. 6.2.2 Kamada Business Overview
  10. 6.2.3 Kamada Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Kamada Alpha-1 Antitrypsin Drugs Product Portfolio
  12. 6.2.5 Kamada Recent Developments
  13. 6.3 Grifols
  14. 6.3.1 Grifols Company Information
  15. 6.3.2 Grifols Business Overview
  16. 6.3.3 Grifols Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Grifols Alpha-1 Antitrypsin Drugs Product Portfolio
  18. 6.3.5 Grifols Recent Developments
  19. 6.4 CSL Behring
  20. 6.4.1 CSL Behring Company Information
  21. 6.4.2 CSL Behring Business Overview
  22. 6.4.3 CSL Behring Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 CSL Behring Alpha-1 Antitrypsin Drugs Product Portfolio
  24. 6.4.5 CSL Behring Recent Developments
  25. 6.5 Baxalta
  26. 6.5.1 Baxalta Company Information
  27. 6.5.2 Baxalta Business Overview
  28. 6.5.3 Baxalta Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Baxalta Alpha-1 Antitrypsin Drugs Product Portfolio
  30. 6.5.5 Baxalta Recent Developments
  31. 6.6 Arrowhead Research Corporation
  32. 6.6.1 Arrowhead Research Corporation Company Information
  33. 6.6.2 Arrowhead Research Corporation Business Overview
  34. 6.6.3 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product Portfolio
  36. 6.6.5 Arrowhead Research Corporation Recent Developments
  37. 6.7 Applied Genetic Technologies Corp
  38. 6.7.1 Applied Genetic Technologies Corp Company Information
  39. 6.7.2 Applied Genetic Technologies Corp Business Overview
  40. 6.7.3 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product Portfolio
  42. 6.7.5 Applied Genetic Technologies Corp Recent Developments
  43. 6.8 Alnylam Pharmaceuticals
  44. 6.8.1 Alnylam Pharmaceuticals Company Information
  45. 6.8.2 Alnylam Pharmaceuticals Business Overview
  46. 6.8.3 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product Portfolio
  48. 6.8.5 Alnylam Pharmaceuticals Recent Developments
  49. 6.9 Abeona Therapeutics
  50. 6.9.1 Abeona Therapeutics Company Information
  51. 6.9.2 Abeona Therapeutics Business Overview
  52. 6.9.3 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product Portfolio
  54. 6.9.5 Abeona Therapeutics Recent Developments
7 North America by Country
  1. 7.1 North America Alpha-1 Antitrypsin Drugs Sales by Country
  2. 7.1.1 North America Alpha-1 Antitrypsin Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Alpha-1 Antitrypsin Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Alpha-1 Antitrypsin Drugs Market Size by Country
  6. 7.2.1 North America Alpha-1 Antitrypsin Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Alpha-1 Antitrypsin Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Alpha-1 Antitrypsin Drugs Sales by Country
  2. 8.1.1 Europe Alpha-1 Antitrypsin Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Alpha-1 Antitrypsin Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Alpha-1 Antitrypsin Drugs Market Size by Country
  6. 8.2.1 Europe Alpha-1 Antitrypsin Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Alpha-1 Antitrypsin Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Alpha-1 Antitrypsin Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Alpha-1 Antitrypsin Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Alpha-1 Antitrypsin Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Alpha-1 Antitrypsin Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Alpha-1 Antitrypsin Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Alpha-1 Antitrypsin Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Alpha-1 Antitrypsin Drugs Sales by Country
  2. 10.1.1 South America Alpha-1 Antitrypsin Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Alpha-1 Antitrypsin Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Alpha-1 Antitrypsin Drugs Market Size by Country
  6. 10.2.1 South America Alpha-1 Antitrypsin Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Alpha-1 Antitrypsin Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Alpha-1 Antitrypsin Drugs Value Chain Analysis
  2. 12.1.1 Alpha-1 Antitrypsin Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Alpha-1 Antitrypsin Drugs Production Mode & Process
  7. 12.2 Alpha-1 Antitrypsin Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Alpha-1 Antitrypsin Drugs Distributors
  10. 12.2.3 Alpha-1 Antitrypsin Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst